Inventor
JOLLY DOUGLAS J
US53 patents
⚠️ This page may combine multiple inventors who share the name “JOLLY DOUGLAS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
15 patentsUS5843723ADec 1, 1998
Alphavirus vector constructs
CHIRON CORP327 citations98
US5789245AAug 4, 1998
Alphavirus structural protein expression cassettes
CHIRON CORP345 citations98
US6015694AJan 18, 2000
Method for stimulating an immune response utilizing recombinant alphavirus particles
CHIRON CORP228 citations97
US5997859ADec 7, 1999
Method for treating a metastatic carcinoma using a conditionally lethal gene
CHIRON CORP46 citations96
US6818439B1Nov 16, 2004
Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders
CHIRON CORP92 citations94
US6133029AOct 17, 2000
Replication defective viral vectors for infecting human cells
CHIRON CORP21 citations92
US5856185AJan 5, 1999
Method for making reflection defective retroviral vectors for infecting human cells
CHIRON CORP32 citations90
US6730297B1May 4, 2004
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
CHIRON CORP41 citations89
US6297048B1Oct 2, 2001
Hepatitis therapeutics
CHIRON CORP29 citations86
US6241982B1Jun 5, 2001
Method for treating brain cancer with a conditionally lethal gene
CHIRON CORP12 citations74
US6410326B1Jun 25, 2002
Method for inhibiting human tumor cells
CHIRON CORP9 citations71
US5698446ADec 16, 1997
Methods and compositions for inhibiting production of replication competent virus
CHIRON CORP17 citations67
US6569679B1May 27, 2003
Producer cell that generates adenoviral vectors encoding a cytokine and a conditionally lethal gene
CHIRON CORP4 citations63
US6531307B1Mar 11, 2003
Adenoviral vectors encoding a cytokine and a conditionally lethal gene
CHIRON CORP3 citations63
US6310045B1Oct 30, 2001
Compositions and methods for cancer immunotherapy
CHIRON CORP4 citations63
VIAGENE INC
7 patentsUS6015686AJan 18, 2000
Eukaryotic layered vector initiation systems
VIAGENE INC253 citations99
US5716613AFeb 10, 1998
Recombinant retroviruses
VIAGENE INC120 citations98
US5716826AFeb 10, 1998
Recombinant retroviruses
VIAGENE INC116 citations98
US5591624AJan 7, 1997
Retroviral packaging cell lines
VIAGENE INC217 citations98
US5716832AFeb 10, 1998
Packaging cells
VIAGENE INC63 citations96
US5693522ADec 2, 1997
Anti-cancer immunotherapeutics
VIAGENE INC70 citations93
US5662896ASep 2, 1997
Compositions and methods for cancer immunotherapy
VIAGENE INC36 citations92
(unassigned)
6 patentsUS5814482ASep 29, 1998
Eukaryotic layered vector initiation systems
536 citations99
US5851529ADec 22, 1998
Recombinant retroviruses
85 citations97
US5888502AMar 30, 1999
Recombinant retroviruses
57 citations96
US5691177ANov 25, 1997
Recombinant retroviruses expressing a protein that converts a pro-drug into a cytotoxic agent
62 citations96
US5830458ANov 3, 1998
Method for destroying a diseased human cell
19 citations92
US6495349B1Dec 17, 2002
Chimeric gene constructs
1 citations62
TOCAGEN INC
5 patentsUS10035983B2Jul 31, 2018
Gene therapy vectors and cytosine deaminases
TOCAGEN INC3 citations72
US9732326B2Aug 15, 2017
Recombinant vectors
TOCAGEN INC3 citations72
US9889133B2Feb 13, 2018
Formulations of 5-fluorocytosine and uses thereof
TOCAGEN INC1 citations61
US10449194B2Oct 22, 2019
Formulations of 5-fluorocytosine and uses thereof
TOCAGEN INC0 citations51
US10407666B2Sep 10, 2019
Recombinant vectors
TOCAGEN INC0 citations51
DENOVO BIOPHARMA LLC
5 patentsUS11065311B2Jul 20, 2021
Retroviral vector with mini-promoter cassette
DENOVO BIOPHARMA LLC2 citations71
US11230719B2Jan 25, 2022
Retroviral vector having immune-stimulating activity
DENOVO BIOPHARMA LLC2 citations69
US11279949B2Mar 22, 2022
Recombinant vectors comprising 2A peptide
DENOVO BIOPHARMA LLC3 citations65
US11191764B2Dec 7, 2021
Formulations of 5-fluorocytosine and uses thereof
DENOVO BIOPHARMA LLC0 citations61
US11060112B2Jul 13, 2021
Producer cells for replication competent retroviral vectors
DENOVO BIOPHARMA LLC0 citations53
GRUBER HARRY E
4 patentsUS9320738B2Apr 26, 2016
Formulations of 5-fluorocytosine and uses thereof
GRUBER HARRY E5 citations83
US8829173B2Sep 9, 2014
Recombinant vectors
GRUBER HARRY E8 citations83
US8722867B2May 13, 2014
Gene therapy vectors and cytosine deaminases
GRUBER HARRY E7 citations83
US9669049B2Jun 6, 2017
Compositions comprising gamma retrovirus vectors and methods of treating proliferative disorders
GRUBER HARRY E6 citations66
UNIV CALIFORNIA
3 patentsNOVARTIS VACCINES & DIAGNOSTIC
2 patentsUNIV IOWA RES FOUND
2 patentsOXFORD BIOMEDICA LTD
1 patentShowing the top 50 of 53 patents by PatentIndex Score.